共 266 条
[71]
Rizzoni D(2005)Effects of hepatic impairment on the pharmacokinetic disposition of nebivolol: a dual acting nitric oxide modulating/cardioselective beta PI-148]. Clin Pharmacol Ther 77 46-40
[72]
Comini S(2005)-antagonist [abstract no PII-101]. Clin Pharmacol Ther 77 77-92
[73]
Van Nueten L(2005)Effects of varying degrees of renal impairment on the pharmacokinetic disposition of nebivolol [abstract no PII-107]. Clin Pharmacol Ther 77 79-85
[74]
Schelling A(1999)Effect of chronic administration of fluoxetine on the pharmacokinetics of nebivolol [abstract no Acta Clin Belg 54 19-9
[75]
Vertommen C(2005)No interaction between nebivolol and digoxin in healthy volunteers [abstract no SENIORS Investigators. Eur Heart J 26 215-58
[76]
Van Bortel LM(2002)Single-dose pharmacokinetics and anticoagulant activity of warfarin is unaffected by nebivolol in healthy volunteers [abstract no Rationale and design. Int J Cardiol 86 77-40
[77]
Bulpitt CJ(2005)No effect of concomitant administration of nebivolol and losartan in healthy volunteers genotyped for CYP2D6 status [abstract no High Blood Press Cardiovasc Prevent 12 27-71
[78]
Fici F(2005)Lack of pharmacokinetic interaction between nebivolol and spironolactone [abstract no Clin Drug Invest 25 409-52
[79]
Mazza A(2003)Pharmacokinetics of nebivolol and ramipril are not affected by co-administration [abstract no JAMA 289 2560-302
[80]
Gil-Extremera B(2004)No pharmacokinetic interaction between nebivolol and furosemide in healthy subjects [abstract no BMJ 328 593-13